Elevatus Welath Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-342,567	Closed	-$2.57M	–	118
2024 Q2	$2.57M	Buy	342,567 +312,917	+1,055%	+$2.35M	0.96%	37
2024 Q1	$296K	Buy	29,650 +5,000	+20%	+$49.9K	0.12%	72
2023 Q4	$243K	Buy	+24,650	New	+$243K	0.11%	75